Home
>
National Drug Code (NDC)
>
Naprelan
Naprelan - 59630-375-10 - (Naproxen Sodium)
Drug Information of Naprelan
| Product NDC: | 59630-375 |
| Proprietary Name: | Naprelan |
| Non Proprietary Name: | Naproxen Sodium |
| Active Ingredient(s): | 375 mg/1 & nbsp; Naproxen Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Naprelan
| Product NDC: | 59630-375 |
| Labeler Name: | Shionogi Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020353 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960401 |
Package Information of Naprelan
| Package NDC: | 59630-375-10 |
| Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59630-375-10) |
NDC Information of Naprelan
| NDC Code | 59630-375-10 |
| Proprietary Name | Naprelan |
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59630-375-10) |
| Product NDC | 59630-375 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Naproxen Sodium |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19960401 |
| Marketing Category Name | NDA |
| Labeler Name | Shionogi Inc. |
| Substance Name | NAPROXEN SODIUM |
| Strength Number | 375 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
